Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v4-EN
Language French English
Date Updated 2018-07-13 2018-04-04
Drug Identification Number 02452499 02452499
Brand name PRIVA-TADALAFIL PRIVA-TADALAFIL
Common or Proper name TADALAFIL 10 MG TADALAFIL 10 MG
Company Name NORA PHARMA INC NORA PHARMA INC
Ingredients TADALAFIL TADALAFIL
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 1X4 1X4
ATC code G04BE G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2018-02-01 2018-02-01
Actual start date 2018-02-01 2018-02-01
Estimated end date 2018-07-27 2018-04-15
Actual end date 2018-07-12
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments